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Edited by Gunnar von Heijne and Anders LiljasAbstract The atomic structures of the large ribosomal subunit
from Haloarcula marismortui and its complexes with substrates
and antibiotics have provided insights into the way the 3000
nucleotide 23S rRNA folds into a compact, speciﬁc structure
and interacts with 27 ribosomal proteins as well as the structural
basis of the peptidyl transferase reaction and its inhibition by
antibiotics. The structure shows that the ribosome is indeed a
ribozyme.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The complete atomic structure of the large ribosomal sub-
unit from Haloarcula marismortui has not only enabled in-
sights into how this large ribonuclear protein machine forms
a compact speciﬁc structure out of RNA and protein compo-
nents, but has also provided many insights into its functions
as the site of peptide-bond formation in protein synthesis
and as a major target of antibacterial antibiotics [1,2].
Although the experimental tools required to establish the
atomic structure of the large ribosomal subunit were largely
in place by the late 1980s, the strategies that enabled the deter-
mination of its structure were only successfully employed 10
years later [3]. An 18 tungsten heavy atom cluster compound,
which was used as a heavy atom derivative, was studied at very
low (20 A˚) resolution where it produced a large and measur-
able signal in the diﬀraction pattern from the subunit crystals.
The extra large signal at this very low resolution results from
the fact that the scatter produced by the cluster compound
at low resolution approaches that of a single heavy atom con-
taining 1332 electrons, which produces X-ray scatter that ap-
proaches 300 times the scatter of a single bound tungsten
heavy atom. The correct positioning of this heavy atom was
conﬁrmed by diﬀerence Fourier using phases produced by
molecular replacement with an cryo-EM reconstruction at 20*Fax: +1 203 432 3282.
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was at 9 A˚ resolution, that showed recognizable features of
RNA rods [3]. Structural studies of the small ribosomal sub-
unit and of the whole 70S ribosome quickly followed similar
strategies [4,5]. From the 2.4 A˚ resolution atomic structure,
the RNA structural database was increased by a factor of 5-
to 6-fold as was the structural database on RNA–protein inter-
actions. A new RNA secondary structure element termed the
‘‘kink-turn’’ was found [6] as well as a major tertiary structure
element in RNA folding termed the ‘‘A-minor motif’’ [7]. The
observation of polypeptide tails extending into the interior of
the RNA to help stabilize its structure was partly anticipated
earlier [8] but visualized in detail in this ﬁrst structure of a ribo-
somal subunit.1.1. The role of RNA in peptide-bond formation
The major functional conclusion from these ﬁrst structural
studies was that the large ribosomal subunit functions as a
ribozyme in catalyzing peptide-bond formation. No protein
component was observed to lie within 18 A˚ of the peptidyl
transferase center and the CCA ends of the A-site and P-site
tRNAs were held in place and positioned entirely by 23S
rRNA and related to each other by a 180 rotation [9].
Although the initial observation that the N3 of A2486
(A2451, Escherichia coli) interacts with the attacking a-amino
group of the A-site aminoacyl-tRNA might suggest that it
might function as a general base to activate the nucleophilic at-
tack of the a-amino group on the carbonyl carbon of the pep-
tidyl-tRNA, subsequent genetic studies have not supported
this hypothesis [10]. However, the more recent ﬁnding that
the 2 0 OH of A76 in the P-site substrate was also hydrogen
bonded to the a-amino group of the aminoacyl-tRNA (Fig.
1) implied that it might also be functioning to properly orient
the a-amino group for attack [11]. Furthermore, it might be
assisting catalysis as a general base to abstract a proton from
the attacking a-amino group and a general acid to donate a
proton to the deacylated 3 0 OH group [11]. Following on ear-
lier biochemical experiments that implicated the 2 0 OH of the
P-site A76 [12], recent kinetic experiments from the Strobel
laboratory have shown that aminoacyl-tRNAs containind a
deoxy-A76 react about 106-fold slower than the ribo-A76
counterpart [13], consistent with the possibility of an impor-
tant role for this 2 0 OH in the catalysis of peptide-bond forma-
tion. However, the alternative possibility that P-site bound
peptidyl-tRNA containing dA76 manifests an altered structureblished by Elsevier B.V. All rights reserved.
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been eliminated.
More recently, additional structures of substrate and inter-
mediate analog complexes with the peptidyl transferase center
have been determined at resolutions ranging from 2.2 to 2.5 A˚
[T.M. Schmeing, K. Huang, S. Strobel, T.A. Steitz, in prepara-
tion, 2004]. The crystal structure of the large subunit bound
simultaneously to two substrates, C-hydroxy puromycin at
the A-site and CCA-phenylalanine-caproic acid-biotin at the
P-site, shows an essentially similar ribosome structure and ori-
entation of the substrates to those structures observed in the
complexes with the individual substrates. Again, the 2 0 OH
of A76 of the P-site peptidyl-CCA interacts with the hydroxyl
group a-amino group mimic of the C-hydroxy puromycin so
that it could assist in catalysis as both a general acid and a gen-
eral base.Attempts thus far to demonstrate the presence of either a
divalent or monovalent cation in the immediate vicinity of pep-
tide-bond formation that could be involved in assisting with
catalysis have not supported the possibility of metal ion
involvement in catalysis [T.M. Schmeing et al., in preparation].
Crystals of theH. marismortui large subunit were soaked in the
manganese and anomalous diﬀerence Fouriers showed no peak
in the peptidyl transferase center (PTC) that would be relevant
to catalysis. Furthermore, substrate containing crystals soaked
in 1.7 M potassium also showed no peak in the PTC. Thus far,
neither manganese nor potassium appear to bind in positions
that would be catalytically important for peptide-bond
formation.
The ﬁrst complex of the 50S subunit with a phosphoryl ana-
log of the tetrahedral carbon intermediate of the peptidyl-
transferase reaction was determined at 3.2 A˚ resolution and
appeared to show an interaction of a non-bridging phosphate
oxygen with A2456 (A2451) [9]. However, a modeling of the
tetrahedral intermediate from the substrate complexes sug-
gested that the oxyanion points away from A2251 [11].
Complexes with many additional analogs of the transition
state in peptide-bond formation have been determined at
2.2–2.5 A˚ resolution [T.M. Schmeing, K. Huang, S. Strobel,
T.A. Steitz, in preparation]. These studies conﬁrm the hypoth-
esis derived from model building [11] that the mimic of the
oxyanion of the tetrahedral carbon intermediate points away
from A2486 (2451) and is interacting with what is likely to
be a water molecule. The extent to which this bound water
molecule can enhance the ribosomes catalytic power by stabi-
lizing the transition state remains to be determined.2. Insights into the mechanisms of antibiotic function and
resistance
In order to provide the structural basis of antibiotic inhibi-
tion of protein synthesis, the structures of H. marismortuiFig. 1 Structural insights into peptide-bond formation. (A) A space-
ﬁlling representation of the complex between the H. marismortui large
subunit and three intact tRNAs added in the positions that the tRNAs
assume when bound to the A, P and E sites of the 70S ribosome. rRNA
is white and ribosomal proteins are yellow. The subunit, which is
oriented in the crown view, has been cut in half along a plane that
passes through the peptide exit tunnel, and the front of the structure
has been removed to expose the polypeptide exit tunnel, which is 100
A˚ long and 12–20 A˚ wide. The active-site area is boxed. (B) A close-up
of the active site showing the peptidyl product CC-puromycin-
phenylalanine-caproic acid-biotin (CC-pmm-pcb; green) bound to
the A-loop (tan) and the deacylated product (CCA; violet) bound to
the P-loop (blue). The N3 of A2486 (A2451 in E. coli; light blue) is
close to the 3 0 OH of the CCA, and the base of U2620 (U2585 in E.
coli; red) has moved close to the new peptide bond and the 3 0OH of
A76. (C) A model of the peptidyltransferase center of the large
ribosomal subunit from H. marismortui with substrates bound to both
the A- and P-site. This model was obtained by superimposing the
structure of an A-site substrate complex on the structure of a P-site
substrate complex. The a-amino group of the A-site substrate
(purpose) is positioned for a pro-S attack on the carbonyl carbon of
the ester linking the peptide moiety of the P-site substrate (green).
Possible hydrogen-bonding interactions involving the a-amino group
and the N3 of A2486 (A2451 in E. coli) and the 2 0OH of A76 are
indicated. The 2 0OH of A2486 (A2451 in E. coli) is also close enough
so that it might interact.
b
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determined [14,15]. Additional complexes with the D. radiodu-
rans 50S subunit were established by the Yonath group [16].
The complexes of the H. marismortui large subunit with 15-
and 16-membered macrolides showed that they block the
egress of the nascent polypeptide down the tunnel and that
the16-membered macrolides form a covalent link between an
ethylaldehyde substituent at its C6 position and the N6 of
A2103 (A2062) (Fig. 2). In these complexes, the N2 of
G2099 (A2058, E. coli) lies buried under the hydrophobic side
of the macrolide ring and it was hypothesized that the desolva-
tion of the N2 required upon macrolide binding reduced their
aﬃnity for ribosomes containing a G at this position rather
than the A that is common to eubacteria [14]. Five other clas-
ses of antibiotics were observed (Fig. 2) to bind at sites that
overlap with the binding sites for the CCA ends of the tRNA
substrates [15].
In order to provide a structural understanding of the sources
of antibiotic resistance mutations in the 50S ribosomal sub-
unit, a genetic system was developed for H. marismortui that
has enabled a production of both RNA and protein mutations
in the 50S subunit isolated from H. marismortui [D. Tu, G.
Blaha, P.B. Moore, T.A. Steitz, submitted, 2004]. Structural
studies of these mutated subunits bound to antibiotics have
provided structural insights into the sources of resistance thatFig. 2. The positions of seven antibiotics and A-site (red) plus P-site
(yellow) substrates bound to the peptidyl transferase center. The
ribosome has been split open to reveal the lumen of the exit tunnel and
adjacent regions of the peptidyl transferase site. Ribosomal compo-
nents are depicted as a continuous surface that is colored green at two
positions where splayed out bases provide hydrophobic binding sties
for small molecules. Seven independently determined co-crystal
structures have been aligned by superimposing the 23S rRNA in each
complex. The positions of sparsomycin (green), puromycin (red),
blasticidin S (pink), chloramphenicol (light blue), carbomycin (dark
blue), anisomycin (yellow) and virginiamycin M (light blue) are shown.
The sites to which each of thee antibiotics bind are all diﬀerent, but
there is extensive overlap.obviate the usefulness of speciﬁc antibiotics. Mutation of
A2058 in E. coli (G2099 in H. marismortui) from an A to a
G reduces the aﬃnity of E. coli ribosomes for erythromycin
by about 104-fold. H. marismortui wild-type ribosomes contain
a G at this position and are thus not able to bind erythromycin
in their crystals even at a concentration of 3 mM [14]. How-
ever, when the 23S rRNA of H. marismortui was mutated at
this position from a G to an A, erythromycin binds to the mac-
rolide binding site at a concentration of 1 micromolar, at least
104 times more tightly [D. Tu, G. Blaha, P.B. Moore, T.A.
Steitz, submitted, 2004]. Thus, this single mutation appears
to reverse the eﬀect of A to G mutation observed in eubacteria.
The orientation of the 14-membered macrolide ring of erythro-
mycin bound to the H. marismortui 50S subunit is identical to
that of telithromycin, essentially identical to that observed for
the 15-membered macrolide azithromycin [14] and extremely
similar to the rings of the 16-membered macrolide family
which includes tylosin [Tu et al., submitted, 2004]. However,
the conformations and orientations of erythromycin and teli-
thromycin diﬀer signiﬁcantly from those derived from the crys-
talline complexes with the D. radiodurans 50S subunit [16].2.1. New antibiotics from structure-based drug design
Microbial resistance to antibiotics is growing and spreading
rapidly, particularly in hospitals [17,18]. About two million
people will acquire an infection in a US hospital this year
and 90 000 of them will die of it. Thus, new approaches to
developing novel antibiotics are clearly needed, and since
about one half of the currently used antibiotics target the ribo-
some, mostly the large subunit, structure-based drug design
using the large subunit structure should be useful. Indeed,
these structures of the H. marismortui large ribosomal subunit
complexed with several families of antibiotics that inhibit pep-
tide-bond formation by binding in the vicinity of the peptidyl
transferase center have been highly enabling for Rib-X Phar-
maceuticals, Inc. to design and synthesize novel compounds
that have the property of being active against bacterial strains
that are resistant to presently used antibiotics such as azithro-
max. Use of the structural information has greatly increased
the speed with which new potential drug candidates can be
developed. Thus, it is anticipated that this ribosome structure
based design eﬀort will lead to new and powerful antibiotics
that will be capable of replacing those antibiotics that become
ineﬀective due to bacterial resistance mutations.
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